Multiple sclerosis in China--history and future

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: L773:1352 4585 OR L773:1477 0970 > (2005-2009) > Multiple sclerosis ...

Details
MARC

Cheng, Q (author)

Multiple sclerosis in China--history and future

Article/chapterEnglish2009

Publisher, publication year, extent ...

2009-05-12
SAGE Publications,2009

Numbers

LIBRIS-ID:oai:prod.swepub.kib.ki.se:118977518
http://kipublications.ki.se/Default.aspx?queryparsed=id:118977518URI
https://doi.org/10.1177/1352458509102921DOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:ref swepub-contenttype
Subject category:art swepub-publicationtype

Notes

Background Multiple sclerosis (MS) is considered rare in China and reports on MS in the English literature are few. Methods A systematic literature search for articles with MS was made, particularly for papers published in the Chinese medical journals from mainland China. Results In China, the first case of MS was described in the medical records from Xiehe hospital in 1926, and the first autopsy case of MS was reported from Huashan hospital in 1957. Although reports on MS based on the information from hospital case-series have been increased gradually in the recent decades, there is no national surveillance on MS frequency in the population and population-based surveys on MS were few in China. Generally for Chinese patients with MS the mean age at onset of MS is around 30 years, with a few cases younger than 20 years; the most frequent site of the lesions in the central nervous system, based on the clinical symptoms or signs, is the spinal cord (usually more than 60%); there are few patients with a family history of MS; almost all patients are treated with corticosteroids. Reported prevalence rates of MS from population surveys in China are rather low (1–2 per 100,000) and higher in females than in males, which are comparable with the results from other populations in Asia. Conclusion The clinical and epidemiological aspects of MS in China are, in general, similar to that from other populations in Asia. Epidemiological studies and national surveillance on MS are required in China.

Added entries (persons, corporate bodies, meetings, titles ...)

Cheng, XJ (author)
Jiang, GXKarolinska Institutet (author)
Karolinska Institutet (creator_code:org_t)

Related titles

In:Multiple sclerosis (Houndmills, Basingstoke, England): SAGE Publications15:6, s. 655-6601352-45851477-0970

Internet link

Find in a library

Multiple sclerosis (Houndmills, Basingstoke, England) (Search for host publication in LIBRIS)

To the university's database

Find more in SwePub

By the author/editor: Cheng, Q; Cheng, XJ; Jiang, GX

Articles in the publication: Multiple scleros ...

By the university: Karolinska Institutet

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se